 |
 |
The MATRICS
Consensus Cognitive Battery (MCCB) is intended to provide a relatively
brief evaluation of key cognitive domains relevant to schizophrenia and
related disorders, and was designed to address the following purposes:
 |
As an outcome
measure for clinical trials of cognition-enhancing drugs for
schizophrenia |
 |
As an outcome measure for
studies of cognitive remediation |
 |
As a measure of cognitive
change in repeated testing applications |
 |
As a cognitive reference point
for non-intervention studies of schizophrenia and related disorders |
|
 |

|
|
 |
 |
 |
The National
Institute of Mental Health (NIMH) Initiative, Measurement and Treatment
Research to Improve Cognition in Schizophrenia (MATRICS), was designed
to stimulate the development of psychopharmacological agents to improve
cognition in schizophrenia. The MATRICS Consensus Cognitive Battery
(MCCB) was one deliverable from this Initiative. The selection of tests
included in the MCCB involved a broad-based interdisciplinary consensus
process that is described in more detail on the MATRICS website
(www.matrics.ucla.edu). The committee members involved with this
process are listed on the MATRICS website as well. |
 |

|
|
 |
|